The VTE-BLEED Score
Introduction
The VTE-BLEED score was developed to identify patients on anticoagulation for VTED and who were at increased risk of bleeding. The original study was based on a post-hoc analysis of patients enrolled in various trials evaluating Dabigatran [a direct Thrombin inhibitor] versus standard treatment with Warfarin and subsequent studies have evaluated patients on Rivaroxaban [a direct Factor Xa inhibitor].
The algorithm is summarised below: